0% found this document useful (0 votes)
9 views47 pages

Biopharmaceutics Lecture 1

Uploaded by

Wegene Benti Uma
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
9 views47 pages

Biopharmaceutics Lecture 1

Uploaded by

Wegene Benti Uma
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 47

Biopharmaceutics

1 By: Merga D.
Outline
2

 Introduction
 Barriers of drug
transport
 Mechanisms of drug
transport

By: Merga D.
Learning outcomes
3

 Upon successful completion of this session, the


student will be able to:
 Define Biopharmaceutics
 Identify barriers of drug transport
 Mechanisms of drug transport

By: Merga D.
Introductory activity
4

 What is Pharmaceutics?
 discipline of pharmacy that deals with all
aspects of the process of turning a new
chemical entity into a medication able to be
safely and effectively used by patients
 put at its most simplistic, it converts a

drug into a medicine

By: Merga D.
Introduction…
5

Biopharmaceutics
a branch of pharmaceutical sciences that concerns the
interrelationship b/n
 the physicochemical properties of a drug
 the dosage form in which the drug is given
 the route of administration
on the rate and extent of systemic drug absorption

By: Merga D.
Introduction…
6

 For a drug to be effective,


 enough amount needs to reach its site(s) of action
 stay at site(s) of action long enough
 This depends upon;
 the route of administration
 the form in which it is administered
 the rate at which it is delivered
By: Merga D.
Introduction…
7

 Drugs may be given by


 parenteral

 enteral
 Other route (transdermal, inhalation, intranasal

Ophthalmic)
for systemic absorption

By: Merga D.
Introduction…
8

 In intravenous route,
 a drug is introduced directly into the bloodstream

 complete (100%) systemic drug availability

 All other routes of administration involve the


absorption of the drug into the blood from the ROA
 does not guarantee that the whole dose will reach

systemic circulation intact

By: Merga D.
Introduction…
9
Clinical
IV effect
E
injection Drug at site (s) L Unchanged
of action I drug
A M excreted
B I
DISTRIBUTIO
S N N
O A
Drug at site R
Bound unbound T
of P
administration drug drug I
T O metabolis
(extravascular)
I N m
O DISTRIBUTIO
N N Metabolites
excreted
Fig.: Drug ADME Drug in tissues (including
blood cells) & other fluid of
By: Sintayehu distribution
By: Merga D.
A 6/29/2021
Introduction…
10

 The relative amount of drug that reaches the systemic


circulation intact and the rate at which this occurs is
known as bioavailability
 Bioavailability is therefore defined as the rate and extent
of drug absorption

By: Merga D.
Introduction…
11

By: Merga D.
Introduction…
12

 it is often difficult to access the drug at its site(s) of


action
 its concentration in the plasma is often taken as a
surrogate for its concentration at its site(s) of action
 Unbound drug in the plasma would give a better
estimate of the concentration of the drug at its site(s)
of action

By: Merga D.
Introduction…
13

 For extravascularly administered drug to be 100%


bioavailable, a drug must be
 completely released from DF

 fully dissolved in body fluids

 stable in solution in body fluids

 pass through physiologic barriers into surrounding

circulation without metabolism


 reach into systemic circulation intact

By: Merga D.
Introduction…
14

 Whenever a drug is administered by any non-vascular


route, rapid and complete absorption into bloodstream is
sought:
 there is relationship between drug concentration in body and
magnitude of therapeutic response
 the greater concentration achieved, the greater magnitude

of response
 it is desired to obtain these concentrations rapidly

By: Merga D.
Introduction…
15

 The concentration of the drug in blood plasma


depends on numerous factors
 These include,
 the amount of an administered dose that is absorbed

and reaches the systemic circulation;


 the extent of distribution of the drug b/n the

systemic circulation and other tissues and fluids;


 the rate of elimination of the drug from the

body

By: Merga D.
Introduction…
16

 The study and characterization of the time course of


drug (ADME) is termed pharmacokinetics

By: Merga D.
Introduction…
17 Bioavailability of drug may be influenced by many
factors

 Physicochemical properties  Site(s) of absorption


of drug  Food
 Type of Dosage form  Disease state
 Dose and frequency of  Co-administration
administration  Age of patient
 Route of administration
A
Others
By: Merga
Sintayehu
D. 6/29/202
1
Introduction…
18

 Factors affecting BA can broadly grouped


into:
 Biological/Physiological factors
 Physicochemical factors
 Dosage form factors

By: Merga D.
Introduction…
19

 Emphasis is on factors influencing oral drug absorption


 Oral route is most popular route of drug administration
 The vast majority of drug dosage forms are designed for
oral ingestion:
 Natural and convenient route
 Relatively easy to manufacture

 need not be sterilized, compact, produced in bulk

By: Merga D.
Barriers to Drug Transport

20 By: Merga D.
Barriers to Drug Transport…
21

 The cytoplasm is held as an intact unit


by a cell membrane,
 which surrounds it and prevents it from

mixing with its surroundings


 allow penetration of some substances

and not others


 selectively permeable
 acts as a permeability barrier

By: Merga D.
Barriers to Drug Transport…
22

 Organs and tissues are collections of cells


surrounded by specialized cell structures
called epithelia,
 which can be thought of as the

organ’s ‘outer membrane’ in an


analogous fashion to the membrane
that surrounds the individual cell
 Like cell membranes, epithelia are the site
for a wide range of transport, barrier and
secretory processes
By: Merga D.
Barriers to Drug Transport…
23

 The barrier has the


characteristics of a
semipermeable membrane,
 allowing the rapid transit of
some materials
 impeding or preventing the
passage of others

By: Merga D.
Barriers to Drug Transport…
24

Epithelia
 Epithelia are a collection of cells

 They line most body surfaces

 With a few exceptions, all internal and

external body surfaces are covered with


epithelium
 This consists of a layer of structural protein,

normally collagen, called the basal lamina, on


which sit one or more layers of epithelial
cells
By: Merga D.
Barriers to Drug Transport…
25

Epithelia…
 There are several morphologically distinct

common epithelial types


 Simple squamous epithelium
 Simple columnar epithelium
 Transitional epithelium
 Stratified squamous epithelium

By: Merga D.
Barriers to Drug Transport…
26

Simple squamous epithelium


 This forms a thin layer of flattened

cells and consequently is relatively


permeable
 Sites

 most of the blood vessels


 lung alveoli
 Function
 Diffusion,filtration
 Secretion and absorption

By: Merga D.
Barriers to Drug Transport…
27

Simple columnar epithelium


 A single layer of columnar cells

attached to the basement membrane


 Sites

 Lines the stomach, SI, LI


 Function
 absorption

 secretion

By: Merga D.
Barriers to Drug Transport…
28

Transitional epithelium
 This is composed of several layers of cells of

different shapes and it lines epithelia which


are required to stretch
 Sites

 lines the organs of the urinary system

By: Merga D.
Barriers to Drug Transport…
29

Stratified squamous epithelium


 Consists of many cells arranged in

layers
 Site

 Lines mouth, oesophagus, the

vagina
 Function

 Protection against abrasion


 Barrier to infection

By: Merga D.
Barriers to Drug Transport…
30

 In order for a drug to reach a site of action,


 it must pass from an external site to
an internal site
 pass through a number of tissues and

epithelia
 Overcoming these barriers to absorption is
one of the most important considerations in
the DD process

By: Merga D.
Mechanisms of drug transport

31 By: Merga D.
Mechanisms…
32

 There are two main mechanisms of drug transport


across the gastrointestinal epithelium:
 Trans-cellular
 Para-cellular

Fig. Mechanisms of absorptive

By: Merga D.
Mechanisms…
33

 The trans-cellular pathway is further divided into


 Simple passive diffusion
 Carrier-mediated transport
 Endocytosis

By: Merga D.
Mechanisms…
34

Trans-cellular pathways
 Passive diffusion:
 transport for relatively small lipophilic molecules
 many drugs transported via this route
 drug molecules pass across cell membrane via a region
of high concentration to a region of lower concentration
 i.e. from lumen to blood

By: Merga D.
Mechanisms…
35

Trans-cellular pathways…
 Carrier-mediated transport:
 The drug require carrier or transporter to
cross membrane
carrier-mediated transport
 Two main types carrier-mediated transport
 Active transport and
 Facilitated diffusion

By: Merga D.
Mechanisms…
36

Trans-cellular pathways…
 Active transport: materials transported

against a concentration gradient


 active transport is an energy consuming process
 A carrier or membrane transporter is responsible for
binding a drug and transporting it across the membrane

By: Merga D.
Mechanisms…
37

Fig: Active transport of a drug aBy:ByMerga


c: SrD.inotasyeshuaA
Mechanisms…
38

Trans-cellular pathways…
 Facilitated diffusion:
 Drugs are transported down the concentration gradient
 does not require an energy
 butdoes require a concentration
gradient

By: Merga D.
Mechanisms…
39

Trans-cellular pathways…
 Endocytosis:
 Endocytosis is the process by which the plasma
membrane of the cell invaginates and the
invaginations become pinched off, forming small
intracellular membrane-bound vesicles that enclose
a volume of material
 Thus material can be transported into the cell
 primary mechanism of transport of macromolecules
By: Merga D.
Mechanisms…
40

Trans-cellular pathways…
 Endocytosis can be further subdivided into four main
processes:
 pinocytosis
 receptor-mediated endocytosis

 phagocytosis

 transcytosis

By: Merga D.
Mechanisms…
41

Trans-cellular pathways…
 Pinocytosis:
 the engulfment of small droplets of extracellular fluid
by membrane vesicles
 The cell will internalize material regardless of its
metabolic importance to that cell
 The fat-soluble vitamins A, D, E and K are absorbed via
pinocytosis

By: Merga D.
Mechanisms…
42

Trans-cellular pathways…
 Receptor-mediated endocytosis
 Many cells within the body have receptors on

their cell surfaces that are capable of binding


with suitable ligands to form ligand-receptor
complexes on the cell surface
 These complexes cluster on the cell surface

and then invaginate and break off from the


membrane to form coated vesicles
By: Merga D.
Mechanisms…
43

Trans-cellular pathways…
 Phagocytosis
 can be defined as the engulfment by the cell membrane
of particles larger than 500 nm.
 This process is important for the absorption of polio

and other vaccines from the gastrointestinal


tract

By: Merga D.
Mechanisms…
44

Trans-cellular pathways…
 Transcytosis
 the process by which the material internalized by the
membrane domain is transported through the
cell and secreted on the opposite side

By: Merga D.
Mechanisms…
45

By: Merga D.
Mechanisms…
46

 Para-cellular pathway
 transport of materials in the aqueous pores b/n the cells
 transport ions such as calcium and for the transport of

sugars, amino acids and peptides at concentrations


above the capacity of their carriers

By: Merga D.
Mechanisms…
47

Efflux of drugs from the intestine


 there are counter-transport efflux proteins

that expel specific drugs back into the lumen


of the GIT after they have been absorbed
 efflux have a detrimental effect on drug BA
 One of the key counter-transport
proteins is P- glycoprotein

By: Merga D.

You might also like